Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value: $405M (100.0% shares, 0.0% debt)

Holdings (18)

ABBV ABBVIE INC. 21.2%

Value $85.97M Shares 1,580,000 Est. Cost $38.85 Unrealized +9.5%

— ARIAD PHARMACEUTICALS INC 18.5%

Value $75.04M Shares 12,850,000 Est. Cost $6.73 Unrealized —

— MEDICINES CO 14.7%

Value $59.48M Shares 1,567,000 Est. Cost $29.38 Unrealized —

DGX QUEST DIAGNOSTICS INC 8.7%

Value $35.34M Shares 575,000 Est. Cost $46.05 Unrealized +23.4%

— AEGERION PHARMACEUTICALS INC 8.6%

Value $34.75M Shares 2,555,000 Est. Cost $22.50 Unrealized —

— INTRA CELLULAR THERAPIES INC 6.3%

Value $25.63M Shares 640,000 Est. Cost $26.55 Unrealized —

MRK MERCK & CO INC NEW 4.9%

Value $19.76M Shares 400,000 Est. Cost $31.29 Unrealized +22.7%

PCRX PACIRA PHARMACEUTICALS INC 3.9%

Value $15.62M Shares 380,000 Est. Cost $61.25 Unrealized 0.0%

AMGN AMGEN INC 3.1%

Value $12.45M Shares 90,000 Est. Cost $104.63 Unrealized +11.1%

ESPR ESPERION THERAPEUTICS INC NE 2.6%

Value $10.57M Shares 448,000 Est. Cost $62.76 Unrealized 0.0%

— APRICUS BIOSCIENCES INC 2.4%

Value $9.526M Shares 6,524,505 Est. Cost $1.73 Unrealized —

— REPROS THERAPEUTICS INC 2.1%

Value $8.413M Shares 1,132,367 Est. Cost $16.90 Unrealized —

— VIVUS INC 1.0%

Value $4.221M Shares 2,573,943 Est. Cost $9.08 Unrealized —

— KINDRED BIOSCIENCES INC 0.9%

Value $3.583M Shares 689,091 Est. Cost $11.56 Unrealized —

— AVEO PHARMACEUTICALS INC 0.7%

Value $2.8M Shares 2,313,759 Est. Cost $1.84 Unrealized —

ANIP ANI PHARMACEUTICALS INC 0.3%

Value $1.225M Shares 31,000 Est. Cost $44.09 Unrealized +29.0%

— CATALYST BIOSCIENCES INC. 0.1%

Value $419K Shares 90,000 Est. Cost $4.66 Unrealized —

— ELEVEN BIOTHERAPEUTICS INC 0.0%

Value $99,000 Shares 41,200 Est. Cost $11.87 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ABBV	ABBVIE INC.	1,580,000	$85.97M	21.2%	$38.85	+9.5%	COM	00287Y109
—	ARIAD PHARMACEUTICALS INC	12,850,000	$75.04M	18.5%	$6.73	—	COM	04033A100
—	MEDICINES CO	1,567,000	$59.48M	14.7%	$29.38	—	COM	584688105
DGX	QUEST DIAGNOSTICS INC	575,000	$35.34M	8.7%	$46.05	+23.4%	COM	74834L100
—	AEGERION PHARMACEUTICALS INC	2,555,000	$34.75M	8.6%	$22.50	—	COM	00767E102
—	INTRA CELLULAR THERAPIES INC	640,000	$25.63M	6.3%	$26.55	—	COM	46116X101
MRK	MERCK & CO INC NEW	400,000	$19.76M	4.9%	$31.29	+22.7%	COM	58933Y105
PCRX	PACIRA PHARMACEUTICALS INC	380,000	$15.62M	3.9%	$61.25	0.0%	COM	695127100
AMGN	AMGEN INC	90,000	$12.45M	3.1%	$104.63	+11.1%	COM	031162100
ESPR	ESPERION THERAPEUTICS INC NE	448,000	$10.57M	2.6%	$62.76	0.0%	COM	29664W105
—	APRICUS BIOSCIENCES INC	6,524,505	$9.526M	2.4%	$1.73	—	COM	03832V109
—	REPROS THERAPEUTICS INC	1,132,367	$8.413M	2.1%	$16.90	—	COM NEW	76028H209
—	VIVUS INC	2,573,943	$4.221M	1.0%	$9.08	—	COM	928551100
—	KINDRED BIOSCIENCES INC	689,091	$3.583M	0.9%	$11.56	—	COM	494577109
—	AVEO PHARMACEUTICALS INC	2,313,759	$2.8M	0.7%	$1.84	—	COM	053588109
ANIP	ANI PHARMACEUTICALS INC	31,000	$1.225M	0.3%	$44.09	+29.0%	COM	00182C103
—	CATALYST BIOSCIENCES INC.	90,000	$419K	0.1%	$4.66	—	COM	14888D109
—	ELEVEN BIOTHERAPEUTICS INC	41,200	$99,000	0.0%	$11.87	—	COM	286221106